These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32984757)

  • 1. Effect of Direct Oral Anticoagulant, Patient, and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation Study.
    MacDougall K; Douketis JD; Li N; Clark NP; Tafur A; D'Astous J; Duncan J; Schulman S; Spyropoulos AC
    TH Open; 2020 Jul; 4(3):e255-e262. PubMed ID: 32984757
    [No Abstract]   [Full Text] [Related]  

  • 2. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.
    Douketis JD; Spyropoulos AC; Duncan J; Carrier M; Le Gal G; Tafur AJ; Vanassche T; Verhamme P; Shivakumar S; Gross PL; Lee AYY; Yeo E; Solymoss S; Kassis J; Le Templier G; Kowalski S; Blostein M; Shah V; MacKay E; Wu C; Clark NP; Bates SM; Spencer FA; Arnaoutoglou E; Coppens M; Arnold DM; Caprini JA; Li N; Moffat KA; Syed S; Schulman S
    JAMA Intern Med; 2019 Nov; 179(11):1469-1478. PubMed ID: 31380891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale.
    Douketis JD; Spyropoulos AC; Anderson JM; Arnold DM; Bates SM; Blostein M; Carrier M; Caprini JA; Clark NP; Coppens M; Dentali F; Duncan J; Gross PL; Kassis J; Kowalski S; Lee AY; Le Gal G; Le Templier G; Li N; MacKay E; Shah V; Shivakumar S; Solymoss S; Spencer FA; Syed S; Tafur AJ; Vanassche T; Thiele T; Wu C; Yeo E; Schulman S
    Thromb Haemost; 2017 Dec; 117(12):2415-2424. PubMed ID: 29212129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study.
    Tafur AJ; Clark NP; Spyropoulos AC; Li N; Kaplovitch E; MacDougall K; Schulman S; Caprini JA; Douketis J
    J Am Heart Assoc; 2020 Oct; 9(19):e017316. PubMed ID: 32969288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Review of Upper Gastrointestinal Bleed Outcomes During Hospital Admission While on Oral Anticoagulation.
    Scibelli N; Mangano A; Raynor K; Wilson S; Singh P
    Cureus; 2021 May; 13(5):e15061. PubMed ID: 34150404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy.
    Hansen-Barkun C; Martel M; Douketis J; Abraham NS; Liederman Z; Kaplovitch E; Schulman S; Spyropoulos AC; Majid A; Barkun AN
    Am J Gastroenterol; 2023 May; 118(5):812-819. PubMed ID: 36434811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of oral anticoagulants in extreme weights.
    Chin-Hon J; Davenport L; Huang J; Akerman M; Hindenburg A
    Thromb Res; 2023 Nov; 231():1-6. PubMed ID: 37738772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
    Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.
    Shaw J; de Wit C; Le Gal G; Carrier M
    J Thromb Haemost; 2017 May; 15(5):925-930. PubMed ID: 28296069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants.
    Testa S; Paoletti O; Legnani C; Dellanoce C; Antonucci E; Cosmi B; Pengo V; Poli D; Morandini R; Testa R; Tripodi A; Palareti G
    J Thromb Haemost; 2018 May; 16(5):842-848. PubMed ID: 29532628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation.
    Kawabata M; Goya M; Maeda S; Yagishita A; Takahashi Y; Sasano T; Hirao K
    Int Heart J; 2020 Sep; 61(5):905-912. PubMed ID: 32921660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
    Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance to perioperative anticoagulation protocols in elderly patients undergoing elective orthopedic procedures: a retrospective observational cohort study on 548 patients.
    Munk L; van Essen T; van der Hoeven C; Nolte PA; Becker ML
    Patient Saf Surg; 2023 Apr; 17(1):9. PubMed ID: 37081479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
    Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
    Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure.
    Douketis JD; Wang G; Chan N; Eikelboom JW; Syed S; Barty R; Moffat KA; Spencer FA; Blostein M; Schulman S
    J Thromb Haemost; 2016 Jan; 14(1):89-97. PubMed ID: 26512880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer.
    Shaw JR; Li N; Abdulrehman J; Stella SF; St John M; Nixon J; Spyropoulos AC; Schulman S; Wang TF; Carrier M; Douketis JD
    J Thromb Haemost; 2024 Mar; 22(3):727-737. PubMed ID: 37949316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing the perioperative patient on direct oral anticoagulants.
    Leitch J; van Vlymen J
    Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant.
    Taoutel R; Ezekowitz MD; Chaudhry UA; Weber C; Hassan D; Gracely EJ; Kamareddine MH; Horn BI; Harper GR
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101130. PubMed ID: 36246771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database.
    Khachatryan A; Doobaree IU; Spentzouris G; Gusto G; Zawaneh Y; Mughal F; Anastassopoulou A; Manu M; Fay M
    Adv Ther; 2023 Feb; 40(2):504-520. PubMed ID: 36399317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.